Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ′/γA mRNA ratio

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 6, 2007, Pages 1243-1249

  Uitte De Willige, S ^a   Rietveld, I M ^a   De Visser, M C H ^a   Vos, H L ^a   Bertina, Rogier M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Downstream sequence element; Fibrinogen gamma; Polyadenylation; Polymorphism

Indexed keywords

CLEAVAGE STIMULATION FACTOR; FIBRINOGEN; MESSENGER RNA;

ARTICLE; DEEP VEIN THROMBOSIS; EXON; GENE CONSTRUCT; GENE DELETION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN CELL; INTRON; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYADENYLATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE TAGGED SITE; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; FIBRINOGEN; HAPLOTYPES; HUMANS; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TRANSFECTION; VENOUS THROMBOSIS;

EID: 34250212572     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02566.x     Document Type: Article

References (31)

1. Mosesson MW. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 1992; 29: 177-88.
2. Herrick S, Blanc-Brude O, Gray A, Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999; 31: 741-6.
3. Kant JA, Fornace AJ Jr, Saxe D, Simon MI, McBride OW, Crabtree GR. Evolution and organization of the fibrinogen locus on chromosome 4: Gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985; 82: 2344-8.
4. Fu Y, Grieninger G. Fib420: A normal human variant of fibrinogen with two extended alpha chains. Proc Natl Acad Sci USA 1994; 91: 2625-8.
5. Francis CW, Marder VJ, Martin SE. Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen. J Biol Chem 1980; 255: 5599-604.
6. Mosesson MW, Finlayson JS, Umfleet RA. Human fibrinogen heterogeneities. 3. Identification of chain variants. J Biol Chem 1972; 247: 5223-7.
7. Wolfenstein-Todel C, Mosesson MW. Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). Proc Natl Acad Sci USA 1980; 77: 5069-73.
8. Wolfenstein-Todel C, Mosesson MW. Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). Biochemistry 1981; 20: 6146-9.
9. Chung DW, Davie EW. Gamma and gamma'chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-6.
10. Fornace AJ Jr, Cummings DE, Comeau CM, Kant JA, Crabtree GR. Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3′ end of the gene produces gamma A and gamma B forms of gamma-fibrinogen. J Biol Chem 1984; 259: 12826-30.
11. Siebenlist KR, Meh DA, Mosesson MW. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry 1996; 35: 10448-53.
12. Meh DA, Siebenlist KR, Mosesson MW. Identification and characterization of the thrombin binding sites on fibrin. J Biol Chem 1996; 271: 23121-5.
13. Lovely RS, Moaddel M, Farrell DH. Fibrinogen gamma'chain binds thrombin exosite II. J Thromb Haemost 2003; 1: 124-31.
14. Pospisil CH, Stafford AR, Fredenburgh JC, Weitz JI. Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin. J Biol Chem 2003; 278: 21584-91.
15. Uitte de Willige S, de Visser MCH, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Genetic variation in the fibrinogen gamma gene increases the risk of deep venous thrombosis by reducing plasma fibrinogen {gamma} 'levels. Blood 2005; 106: 4176-83.
16. Nickerson D. SeattleSNPs. NHLBI Program for Genomic Applications, Seattle, WA: UW-FHCRC, 2003 http://pga.gs.washington.edu.
17. Beyer K, Dandekar T, Keller W. RNA ligands selected by cleavage stimulation factor contain distinct sequence motifs that function as downstream elements in 3′-end processing of pre-mRNA. J Biol Chem 1997; 272: 26769-79.
18. MacDonald CC, Wilusz J, Shenk T. The 64-kilodalton subunit of the CstF polyadenylation factor binds to pre-mRNAs downstream of the cleavage site and influences cleavage site location. Mol Cell Biol 1994; 14: 6647-54.
19. Weiss EA, Gilmartin GM, Nevins JR. Poly(A) site efficiency reflects the stability of complex formation involving the downstream element. EMBO J 1991; 10: 215-9.
20. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: E45.
21. van der Meer FJM, Koster T, Vandenbroucke JP, Briët E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997; 78: 631-5.
22. Kyburz A, Friedlein A, Langen H, Keller W. Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of Pre-mRNA 3′ end processing and splicing. Mol Cell 2006; 23: 195-205.
23. Chen JM, Ferec C, Cooper DN. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: General principles and overview. Hum Genet 2006; 120: 1-21.
24. Chen JM, Ferec C, Cooper DN. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: The importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants. Hum Genet 2006; 120: 301-33.
25. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
26. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, Kulozik AE. Increased efficiency of mRNA 3′ end formation: A new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 2001; 28: 389-92.
27. Ceelie H, Spaargaren-van Riel CC, Bertina RM, Vos HL. G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3′-end formation. J Thromb Haemost 2004; 2: 119-27.
28. Wylenzek M, Geisen C, Stapenhorst L, Wielckens K, Klingler KR. A novel point mutation in the 3′ region of the prothrombin gene at position 20221 in a Lebanese/Syrian family. Thromb Haemost 2001; 85: 943-4.
29. Balim Z, Kosova B, Falzon K, Bezzina WS, Colak Y. Budd-Chiari syndrome in a patient heterozygous for the point mutation C20221T of the prothrombin gene. J Thromb Haemost 2003; 1: 852-3.
30. Schrijver I, Lenzi TJ, Jones CD, Lay MJ, Druzin ML, Zehnder JL. Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation. J Mol Diagn 2003; 5: 250-3.
31. Danckwardt S, Gehring NH, Neu-Yilik G, Hundsdoerfer P, Pforsich M, Frede U, Hentze MW, Kulozik AE. The prothrombin 3′ end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. Blood 2004; 104: 428-35.